BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26667412)

  • 21. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA; Lokhandwala MF
    Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
    Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
    J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice.
    Li XC; Navar LG; Shao Y; Zhuo JL
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F586-93. PubMed ID: 17537986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Exposure of Fine Particulate Matter Causes Hypertension by Impaired Renal D
    Lu X; Ye Z; Zheng S; Ren H; Zeng J; Wang X; Jose PA; Chen K; Zeng C
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29307864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin.
    Verlander JW; Hong S; Pech V; Bailey JL; Agazatian D; Matthews SW; Coffman TM; Le T; Inagami T; Whitehill FM; Weiner ID; Farley DB; Kim YH; Wall SM
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1314-25. PubMed ID: 21921024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GRK4-mediated adiponectin receptor-1 phosphorylative desensitization as a novel mechanism of reduced renal sodium excretion in hypertension.
    Zhang Y; Wang S; Huang H; Zeng A; Han Y; Zeng C; Zheng S; Ren H; Wang Y; Huang Y; Jose PA; Ma XL; Zeng C; Chen K
    Clin Sci (Lond); 2020 Sep; 134(18):2453-2467. PubMed ID: 32940654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Kidneys in Sex Differences in Angiotensin II-Induced Hypertension.
    Wang L; Wang X; Qu HY; Jiang S; Zhang J; Fu L; Buggs J; Pang B; Wei J; Liu R
    Hypertension; 2017 Dec; 70(6):1219-1227. PubMed ID: 29061720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.
    Lochard N; Thibault G; Silversides DW; Touyz RM; Reudelhuber TL
    Circ Res; 2004 Jun; 94(11):1451-7. PubMed ID: 15117826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
    Harada N; Shimozawa N; Okajima K
    Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique mode of binding between angiotensin II type 1 receptor and its blockers.
    Matsuo Y; Suematsu Y; Tomita S; Tashiro K; Kuwano T; Kitajima K; Miura SI
    Clin Exp Hypertens; 2019; 41(8):747-752. PubMed ID: 30453795
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine Receptor D
    Zeng C; Armando I; Yang J; Jose PA
    Yale J Biol Med; 2023 Mar; 96(1):95-105. PubMed ID: 37009199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension.
    Nishimura A; Sunggip C; Tozaki-Saitoh H; Shimauchi T; Numaga-Tomita T; Hirano K; Ide T; Boeynaems JM; Kurose H; Tsuda M; Robaye B; Inoue K; Nishida M
    Sci Signal; 2016 Jan; 9(411):ra7. PubMed ID: 26787451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice.
    Blakely PK; Huber AK; Irani DN
    J Neuroinflammation; 2016 Aug; 13(1):196. PubMed ID: 27562117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats.
    Heijnen BF; Van Essen H; Schalkwijk CG; Janssen BJ; Struijker-Boudier HA
    Hypertens Res; 2014 Feb; 37(2):100-9. PubMed ID: 23985702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paternal long-term PM2.5 exposure causes hypertension via increased renal AT1R expression and function in male offspring.
    Hu C; Tao Y; Deng Y; Cai Q; Ren H; Yu C; Zheng S; Yang J; Zeng C
    Clin Sci (Lond); 2021 Nov; 135(22):2575-2588. PubMed ID: 34779863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.
    Rayner B; Ramesar R
    Int J Mol Sci; 2015 Mar; 16(3):5741-9. PubMed ID: 25775155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression.
    Ohnuma Y; Toda M; Fujita M; Hosono K; Suzuki T; Ogawa Y; Amano H; Kitasato H; Hayakawa K; Majima M
    Biomed Pharmacother; 2009 Feb; 63(2):136-45. PubMed ID: 18691848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.
    Yang J; Hall JE; Jose PA; Chen K; Zeng C
    Pharmacol Ther; 2022 Nov; 239():108194. PubMed ID: 35487286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.